Search Clinical Pathways
Clinical Pathway for Pancreatic Enzyme Replacement Therapy (PERT) in Children with or at Risk for Exocrine Pancreatic Insufficiency (EPI)
Guidelines for evaluating patients suspected to have exocrine pancreatic insufficiency and initiating/optimizing pancreatic enzyme replacement therapy.
Pulmonary Hypertension Screening in Patients with Bronchopulmonary Dysplasia Clinical Pathway — ICU and Inpatient
Inpatient Clinical Pathway to standardize the process to screen for pulmonary hypertension in infants with Bronchopulmonary Dysplasia (BPD). BPD remains a major source of morbidity and mortality for extremely low birth weight infants.
Central Diabetes Insipidus (DI)/Arginine Vasopressin Deficiency (AVP-D) Clinical Pathway – PICU
The PICU central diabetes insipidus pathway provides guidance for the care of patients with known or suspected central diabetes insipidus requiring ICU care.
22q11.2 Hypocalcemia Screening/Treatment Clinical Pathway — Inpatient, Outpatient Specialty Care and PICU
Peri- procedure and post-procedure calcium surveillance and management for pediatric patients with 22q11.2 diagnosis.
Transposition of the Great Arteries (TGA) Clinical Pathway — CICU
The TGA clinical pathway outlines the care necessary for an inpatient newborn with Transposition of the Great Arteries (TGA) in a step-by-step manner in order to aid clinicians in the treatment.
Post-Cath Pulse Loss Clinical Pathway — ICU and Inpatient
The femoral artery loss clinical pathway outlines the steps to be taken in the case of femoral artery loss in an inpatient setting.
Steroid Stress Dosing and Weaning Clinical Pathway- All settings
The glucocorticoid tapering and stress dose pathway outlines the steps to be taken when a child on steroids needs stress dosing or tapering.
Suspected Acute Heart Failure Clinical Pathway — Emergency Department, ICU and Inpatient
The heart failure clinical pathway outlines the steps to be taken when treating a patient with suspected acute heart failure.
PDA Management in the First Month in High-risk Preterm Neonate Clinical Pathway — ICU and Inpatient
The pathway for management of PDA in the first month of the high risk pre-term neonate outlines the care for high risk neonates while decreasing variability in evaluation and treatment, standardizing echocardiographic readings and decreasing NPO time.
Newborn Persistent Hypoglycemia Clinical Pathway — N/IICU
The Persistent Hypoglycemia, Newborn clinical pathway standardizes and describes the initial evaluation and treatment of persistent hypoglycemia in the neonate.